Annual report pursuant to Section 13 and 15(d)

Equity Incentive Plan (Tables)

v3.21.1
Equity Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2020
Equity Incentive Plan  
Schedule of stock option activity

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted-Average

 

 

 

 

 

Weighted-

Remaining

 

 

 

 

Average

 

Contractual Life

 

    

Number of Options

    

Exercise Price

    

(In Years)

Outstanding at December 31, 2018

 

138,324

 

$

34.17

 

5.95

Granted

 

49,994

 

 

7.20

 

 

Expired

 

(9,274)

 

 

28.58

 

  

Forfeited

 

(4,869)

 

 

9.19

 

  

Outstanding at December 31, 2019

 

174,175

 

$

27.42

 

6.22

Granted

 

93,165

 

 

6.31

 

 

Expired

 

(17,114)

 

 

10.59

 

 

Forfeited

 

(3,333)

 

 

7.20

 

 

Outstanding at December 31, 2020

 

246,893

 

$

20.90

 

7.20

Exercisable at December 31, 2020

 

142,061

 

$

31.58

 

5.85

Vested and Expected to Vest at December 31, 2020

 

246,893

 

$

20.90

 

7.20

 

Schedule of weighted average assumptions

 

 

 

 

 

 

 

    

2020

    

2019

 

Risk-Free Interest Rate

 

1.82

%  

1.82

%

Expected Life

 

5.00 years

 

5.00 years

 

Expected Volatility

 

153

%  

152

%

Expected Dividend Yield

 

 0

%  

 0

%

 

Schedule of restricted stock activity

 

 

 

 

 

 

 

 

 

    

 

    

Weighted-Average

    

Weighted-Average

 

 

Number of

 

Grant Date Fair

 

Remaining

 

    

Shares

    

Value

    

Recognition Period

Non-vested Outstanding at December 31, 2018

 

121,478

 

$

8.84

 

 

Vested

 

(63,632)

 

 

9.00

 

 

Forfeited

 

(7,659)

 

 

8.86

 

  

Non-vested Outstanding at December 31, 2019

 

50,187

 

 

8.64

 

1.49

Awarded

 

49,000

 

 

6.55

 

  

Vested

 

(31,767)

 

 

8.69

 

 

Non-vested Outstanding at December 31, 2020

 

67,420

 

$

7.10

 

1.66

 

Schedule of stock-based compensation expense

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2020

    

2019

 

 

 

 

 

 

 

Research and Development

 

$

197,806

 

$

203,512

General and Administrative

 

 

526,050

 

 

648,718

Total Stock-Based Compensation Expense

 

$

723,856

 

$

852,230